Multidrug-resistant Streptococcus pneumoniae from India [6]

Lancet

Volumn 359, Issue 9304, 2002, Pages 445-

  Lalitha, M K ^a   Pai, Rekha ^b   Manoharan, Anand ^b   Appelbaum, P C ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PENICILLIN G;

BACTERIUM IDENTIFICATION; CHILD; CONTROLLED STUDY; HUMAN; INDIA; INFECTION RISK; LABORATORY TEST; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0013528385     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07578-5     Document Type: Letter

References (5)

1. Spread of drug resistant Streptococcus pneumoniae in Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study
2. Emergence of multidrug resistant pneumococci in India
3. Prospective multicenter hospital surveillance of Streptococcus pneumoniae disease in India
4. Changing trend in susceptibility pattern of Streptococcus pneumoniae to penicillin in India
5. Streptococcus